Spanish animal-health regulator logs licence updates for 92 product entries and flags gaps in recall execution
AEMPS says the problems arose in following up a withdrawal of product batches, a process that involves licence holders, distributors, pharmacies and regional inspectors.
17 Nov 2026 · AEMPS · Regulator
Spain's medicines agency AEMPS has reported weaknesses in how a recent product withdrawal was carried out in the animal-health supply chain. The point emerged from the third joint meeting of 2026 of two veterinary advisory bodies, held on 12 November. AEMPS published the outcome on 17 November as MVET (CSMV) 03/2026.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
or
Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.
More Approvals & launchesAll →
Approvals & launches
NeOnc to meet FDA in January 2027 on NEO100 accelerated approval path
18 Nov 2026 · Neonc Technologies Holdings, Inc. NTHI · Company news
Approvals & launches
FDA approves Novartis' Cosentyx 150 mg for polymyalgia rheumatica
17 Nov 2026 · Novartis Pharma AG · Company news
Approvals & launches
FDA approves Roche's Wilserdly with everolimus for ESR1-mutated advanced breast cancer
16 Nov 2026 · Roche · Company news
Approvals & launches
FDA approves Roche's oral SERD Wilserdly with everolimus for ESR1-mutated breast cancer
16 Nov 2026 · F. Hoffmann-La Roche Ltd · Company news
Approvals & launches
Larimar completes BLA submission for nomlabofusp in Friedreich's ataxia, seeking accelerated approval
16 Nov 2026 · Larimar Therapeutics, Inc. LRMR · Company news
Approvals & launches
FDA grants Breakthrough Therapy status to daretabart for newly diagnosed high-risk neuroblastoma in children
16 Nov 2026 · Essential Pharma · Company news